Malcisbo Email Formats

Biotechnology Research • Switzerland • 1-10 Employees

Malcisbo Email Formats

Malcisbo uses 1 email format. The most common is {first initial}.{last name} (e.g., j.doe@malcisbo.com), used 100% of the time.

Format	Example	Percentage
{first initial}.{last name}	j.doe@malcisbo.com	100%

Key Contact at Malcisbo

Lino Camponovo

CEO

Company overview

Headquarters	Switzerland
Phone number	+41447322200
Website	malcisbo.com
NAICS	541714
SIC	283
Employees	1-10
Socials

About Malcisbo

Sweet vaccines are novel carbohydrate based vaccines being developed by the company Malcisbo. The first targets are unmet medical needs such as Campylobacter induced food poisoning and parasitic infections by the blood sucking stomach worm Hemonchus in sheep causing losses in food production. Malcisbo has developed a proprietary target discovery platform which it will use in combination with glycoengineering technologies to provide novel and efficient glycoconjugate vaccines. The discovery platform will generate a constant outflow of novel vaccines for unmet human and veterinary medical needs. Further projects are affordable vaccines to protect people in underdeveloped areas against parasitic worm infections.